跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,588 条关于
“Loxo@Lilly”
全部
1,588
临床试验
176
药物
322
机构
23
资讯
1,067
去年
Eli Lilly Advances LOXO-435 in Phase 1 FORAGER-1 Study for FGFR3-Altered Advanced Cancers
去年
Eli Lilly and Loxo Oncology Advance Phase 3 Trial Testing Pirtobrutinib Combination for Previously Treated CLL/SLL
2年前
Eli Lilly Acquires Point Biopharma for $1.4 Billion to Expand Radioligand Therapy Portfolio
去年
FDA Expands Verzenio Approval in Early Breast Cancer and Removes Menopausal Restriction
3年前
Pirtobrutinib Shows Promising Efficacy in CLL/SLL Patients After BTK Inhibitor Failure
3年前
Major Kinase Inhibitor Summit to Showcase Next-Generation Cancer Therapeutics Advances
去年
Advancements in HER2-Positive Gastric Cancer Treatment Landscape
7个月前
OnKure Faces Critical Data Readout for H1047R-Specific PI3Kα Inhibitor as Competition Intensifies
去年
Eli Lilly Acquires Scorpion's Cancer Drug STX-478 in $2.5 Billion Deal
去年
FDA Grants Full Approval to Selpercatinib for RET-Mutant Medullary Thyroid Cancer
第 1 页,共 107 页
上一页
下一页